BLA

• Press releases
• Country: United States

Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism

The Agency reiterated its commitment to addressing the unmet need for treatment of congenital and tumor-related hyperinsulinism and to serving these patient communities

• Country: India

FIR against K'taka BJP BLA-1, officials over attempt to seek deletion of 7,561 voters in Ballari

The case has been registered against Srinivas Motkar, Ballari City Corporation corporator and BJP BLA-1, Assistant Commissioner Nandeesh, Booth Level Officer (BLO) Sumalatha, and case worker Sharanabasava, based on a complaint filed by Gowtham, a Congress Booth Level Agent (BLA) for Ward No. 23…

• Country: India

FIR against BJP BLA for ‘false’ Form 7s in Malleshwaram

• Press releases
• Country: United States

Novo provides update on the denecimig Biologics License Application (BLA) in the US

Bagsværd, Denmark, 02 October 2026 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has informed Novo that the BLA review of denecimig for the treatment of haemophilia A, with or without inhibitors in adults and children, is still ongoing. The FDA has not communicated a…